NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Schizophrenia
In brief
The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.
Key facts
- Study ID
- NCT06963034
- Run by
- Neurocrine Biosciences
- People needed
- 284
- Starts
- 2025-05-08
- Expected to finish
- 2027-10-01
- Last updated by the study team
- 2026-03-06
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Neurocrine Clinical Site — Bryant, Arkansas, United States (enrolling)
- Neurocrine Clinical Site — Little Rock, Arkansas, United States (enrolling)
- Neurocrine Clinical Site — Anaheim, California, United States (enrolling)
- Neurocrine Clinical Site — Pico Rivera, California, United States (enrolling)
- Neurocrine Clinical Site — San Diego, California, United States (enrolling)
- Neurocrine Clinical Site — Sherman Oaks, California, United States (enrolling)
- Neurocrine Clinical Site — Torrance, California, United States (enrolling)
- Neurocrine Clinical Site — Hollywood, Florida, United States (enrolling)
- Neurocrine Clinical Site — Miami Lakes, Florida, United States (enrolling)
- Neurocrine Clinical Site — Atlanta, Georgia, United States (enrolling)
- Neurocrine Clinical Site — Decatur, Georgia, United States (enrolling)
- Neurocrine Clinical Site — Snellville, Georgia, United States (enrolling)
- Neurocrine Clinical Site — Chicago, Illinois, United States (enrolling)
- Neurocrine Clinical Site — Gaithersburg, Maryland, United States (enrolling)
- Neurocrine Clinical Site — Watertown, Massachusetts, United States (enrolling)
- Neurocrine Clinical Site — Marlton, New Jersey, United States (enrolling)
- Neurocrine Clinical Site — Staten Island, New York, United States (enrolling)
- Neurocrine Clinical Site — The Bronx, New York, United States (enrolling)
- Neurocrine Clinical Site — Austin, Texas, United States (enrolling)
- Neurocrine Clinical Site — DeSoto, Texas, United States (enrolling)
- Neurocrine Clinical Site — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.